🇺🇸 FDA
Pipeline program

tamuzimod, tamuzimod, tamuzimod, VTX002 placebo film-coated tablets matching VTX002, tamuzimod

VTX002-201

Phase 2 small_molecule active

Quick answer

tamuzimod, tamuzimod, tamuzimod, VTX002 placebo film-coated tablets matching VTX002, tamuzimod for Moderately to Severely Active Ulcerative Colitis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Moderately to Severely Active Ulcerative Colitis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials